Most bought healthcare stocks in Q2 2014
See which Healthcare stocks institutional investors increased the most in Q2 2014, measured as net growth in reported share positions from Q1 2014 into Q2 2014. Notable additions at the top of this list include GILEAD SCIENCES INC (GILD), NOVARTIS AG-SPONSORED ADR (NVS), HCA HEALTHCARE INC (HCA), PATTERSON COS INC (PDCO). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| GILD | GILEAD SCIENCES INC | 6,092,357 | $570.72M | 4 | 4 | 2 | 1 | 12 |
| NVS | NOVARTIS AG-SPONSORED ADR | 4,920,524 | $725.34M | 1 | 2 | 5 | 0 | 10 |
| HCA | HCA HEALTHCARE INC | 3,574,659 | $201.54M | 3 | 0 | 0 | 0 | 3 |
| PDCO | PATTERSON COS INC | 2,966,062 | $95.25M | 1 | 2 | 2 | 1 | 5 |
| EXAS | EXACT SCIENCES CORP | 2,000,000 | $34.06M | 1 | 0 | 0 | 0 | 1 |
| REGN | REGENERON PHARMACEUTICALS | 1,903,945 | $515.17M | 1 | 1 | 1 | 0 | 3 |
| UNH | UNITEDHEALTH GROUP INC | 1,879,441 | $145.47M | 0 | 4 | 3 | 2 | 8 |
| BAX | BAXTER INTERNATIONAL INC | 1,526,503 | $102.49M | 0 | 4 | 3 | 0 | 8 |
| HALO | HALOZYME THERAPEUTICS INC | 1,514,962 | $10.54M | 0 | 2 | 0 | 0 | 2 |
| MYGN | MYRIAD GENETICS INC | 1,407,559 | $52.78M | 2 | 0 | 2 | 1 | 4 |
| A | AGILENT TECHNOLOGIES INC | 1,382,537 | $85.08M | 1 | 1 | 1 | 0 | 4 |
| EXEL | EXELIXIS INC | 1,258,150 | $4.21M | 1 | 0 | 0 | 1 | 1 |
| ACAD | ACADIA PHARMACEUTICALS INC | 1,159,471 | $19.93M | 0 | 1 | 0 | 0 | 1 |
| OMCL | OMNICELL INC | 1,083,579 | $31.11M | 1 | 1 | 0 | 0 | 2 |
| MCK | MCKESSON CORP | 998,211 | $185.88M | 2 | 0 | 0 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | 956,503 | $39.01M | 0 | 2 | 4 | 1 | 7 |
| DHR | DANAHER CORP | 942,790 | $80.59M | 0 | 2 | 2 | 0 | 4 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | 938,030 | -$69.78M | 0 | 3 | 0 | 0 | 3 |
| HOLX | HOLOGIC INC | 909,723 | $6.16B | 1 | 0 | 2 | 1 | 5 |
| BDX | BECTON DICKINSON AND CO | 885,203 | $115.11M | 3 | 4 | 4 | 0 | 12 |
| NVO | NOVO-NORDISK A/S-SPONS ADR | 877,754 | $49.27M | 1 | 1 | 0 | 0 | 3 |
| RDNT | RADNET INC | 798,900 | $5.30M | 1 | 0 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 791,395 | $103.64M | 1 | 2 | 5 | 0 | 9 |
| CNC | CENTENE CORP | 696,457 | $55.31M | 1 | 0 | 1 | 0 | 2 |
| GMED | GLOBUS MEDICAL INC - A | 553,807 | $12.63M | 0 | 1 | 0 | 1 | 1 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 500,773 | $25.50M | 1 | 1 | 1 | 0 | 5 |
| GERN | GERON CORP | 493,872 | $5.04M | 0 | 1 | 0 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | 474,681 | $225.86M | 0 | 7 | 9 | 0 | 20 |
| MGNX | MACROGENICS INC | 334,285 | $7.26M | 1 | 0 | 0 | 0 | 1 |
| CVS | CVS HEALTH CORP | 287,914 | $31.72M | 1 | 3 | 3 | 0 | 10 |
| ARAY | ACCURAY INC | 281,483 | $2.28M | 0 | 1 | 0 | 0 | 1 |
| MASI | MASIMO CORP | 262,235 | $6.19M | 1 | 0 | 0 | 0 | 1 |
| PRGO | Perrigo Company PLC | 247,620 | $22.79M | 0 | 1 | 0 | 0 | 1 |
| RGEN | REPLIGEN CORP | 241,207 | $10.12M | 0 | 1 | 0 | 0 | 1 |
| EW | EDWARDS LIFESCIENCES CORP | 223,763 | -$4.05M | 1 | 1 | 0 | 0 | 2 |
| AMGN | AMGEN INC | 220,533 | $23.72M | 1 | 1 | 3 | 2 | 5 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 215,700 | $7.22M | 1 | 0 | 0 | 0 | 1 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 214,200 | $32.98M | 0 | 1 | 1 | 0 | 3 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 210,380 | $12.70M | 0 | 1 | 0 | 0 | 1 |
| OSUR | ORASURE TECHNOLOGIES INC | 202,879 | $1.90M | 0 | 1 | 0 | 0 | 1 |
| AMED | AMEDISYS INC | 193,921 | $3.51M | 0 | 1 | 0 | 0 | 1 |
| WST | WEST PHARMACEUTICAL SERVICES | 187,300 | $5.25M | 0 | 1 | 0 | 0 | 1 |
| AMRN | AMARIN CORP PLC -ADR | 184,200 | $324.00K | 1 | 0 | 0 | 0 | 1 |
| MDXG | MIMEDX GROUP INC | 179,900 | $1.27M | 1 | 0 | 0 | 0 | 1 |
| CNMD | CONMED CORP | 165,079 | $7.32M | 0 | 1 | 0 | 0 | 1 |
| ALKS | ALKERMES PLC | 161,376 | $8.46M | 0 | 1 | 0 | 0 | 1 |
| HBIO | HARVARD BIOSCIENCE INC | 155,826 | $598.00K | 0 | 1 | 0 | 0 | 1 |
| SIGA | SIGA TECHNOLOGIES INC | 141,005 | $357.00K | 0 | 1 | 0 | 0 | 1 |
| SGMO | SANGAMO THERAPEUTICS INC | 136,380 | $959.00K | 0 | 1 | 0 | 0 | 1 |
| ANIP | ANI PHARMACEUTICALS INC | 117,702 | $4.05M | 1 | 0 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q2 2014
What are the most bought Healthcare stocks in Q2 2014?
The most bought healthcare stocks in Q2 2014 are those with the largest increase in reported share counts across institutional investors compared to Q1 2014, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q2 2014?
Among filers in this sector, net additions were largest in companies such as GILEAD SCIENCES INC (GILD), NOVARTIS AG-SPONSORED ADR (NVS), HCA HEALTHCARE INC (HCA), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q1 2014).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.